Last week I was called by a friend who opened the conversation by saying: “So you were wrong about statins.” He was referring to the correction that the British Medical Journal (BMJ) has had to make in two papers that claimed statins have a high level of side effects. But I certainly haven’t recanted and started popping those pills.
Given the huge amount of attention this has attracted, the actual point being “corrected” is remarkably small. It is the kind of thing that would normally be dealt with by publishing a response to the article in the journal. I’ll come to the specifics in a moment but first a bit of context…. (Read more…)
Current Posts – 18 July 2014
Next week we will learn whether statins are going to be given to millions more healthy people. Normally such extensions of drug use are nodded through without a murmur but his time a serious challenge was raised. A fierce debate about whether this was a disastrous idea or welcome move to save the nation’s hearts. The result was a series of revelations about the tangled conflicts of interests surrounding these drugs. Questions that should lead to big changes in the way they are tested and guidelines drawn up. Read more in Hannah Sutter’s article…